Know Cancer

or
forgot password
  • cancer clinical trials in alaska

  • Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Providence Alaska Medical Center
    Anchorage, Alaska 99508
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
    Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital
    Fairbanks, Alaska 99701
    Brain and Central Nervous System Tumors
    S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
    Alaska Regional Hospital Cancer Center
    Anchorage, Alaska 99508
    Head and Neck Cancer
    Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Anchorage, Alaska 99508
    Small Cell Lung Cancer
    Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    Alaska Oncology and Hematology LLC
    Anchorage, Alaska 99508
    Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx
    Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
    Alaska Heart Institute
    Anchorage, Alaska 99508
    Atrial Fibrillation, Atrial Flutter
    Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)
    Providence Alaska Medical Center
    Anchorage, Alaska 99508
    Prostate Cancer
    Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.
    Alaska Cancer Research and Education Center
    Anchorage, Alaska 99508
    Cachexia
    Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer
    Sanofi-Aventis Investigational Site Number 840068
    Anchorage, Alaska 99508
    Urinary Bladder Neoplasms
    A Study of Leuprolide to Treat Prostate Cancer
    Site Reference ID/Investigator# 8569
    Anchorage, Alaska 99508
    Prostate Cancer
    Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer
    Alaska Urological Association
    Anchorage, Alaska 99508
    Prostate Cancer
    Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
    Fairbanks Memorial Hospital
    Fairbanks, Alaska 99701
    Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes
    SWOG-8819 Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin's Lymphoma
    Alaska Regional Hospital Cancer Center
    Anchorage, Alaska 99508
    Lymphoma
    S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
    Providence Cancer Center
    Anchorage, Alaska 99508
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    SWOG-8947 Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
    Alaska Regional Hospital Cancer Center
    Anchorage, Alaska 99508
    Lymphoma
    Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
    Alaska Clinical Research Center, LLC
    Anchorage, Alaska 99508
    Bladder Neoplasm, Intravesical Drug Administration, Neoplasm Recurrence, Local, Transitional Cell, Carcinoma, Carcinoma in Situ, Mycobacterium